CNCR vs. IHE ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to iShares U.S. Pharmaceutical ETF (IHE)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$29.01

Average Daily Volume

6,604

Number of Holdings *

27

* may have additional holdings in another (foreign) market
IHE

iShares U.S. Pharmaceutical ETF

IHE Description The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$178.69

Average Daily Volume

7,479

Number of Holdings *

45

* may have additional holdings in another (foreign) market
Performance
CNCR IHE
30 Days -7.64% -0.46%
60 Days -12.28% -2.64%
90 Days -17.46% -3.98%
12 Months 23.18% 18.94%
1 Overlapping Holdings
Grade Symbol Weight in CNCR Weight in IHE Overlap
B BMY 4.04% 4.72% 4.04%
CNCR Overweight 26 Positions Relative to IHE
Grade Symbol Weight
C IMAB 5.71%
B MGNX 5.21%
D BGNE 4.97%
D ALLO 4.4%
B BNTX 4.33%
F NKTR 4.2%
D RCUS 4.15%
B GILD 4.09%
C REGN 3.89%
F ARGX 3.68%
D XNCR 3.66%
C AZN 3.49%
D LEGN 3.42%
D GMAB 3.37%
D FATE 3.1%
D MOR 3.03%
F CRSP 2.85%
F REPL 2.57%
F BLUE 2.46%
F SRRK 2.39%
F IGMS 2.32%
D IOVA 2.26%
F ATRA 2.04%
F ALXO 2.01%
F YMAB 1.87%
F NKTX 1.81%
CNCR Underweight 44 Positions Relative to IHE
Grade Symbol Weight
C JNJ -22.5%
B PFE -18.16%
C MRK -5.59%
B ZTS -4.89%
D CTLT -4.81%
C HZNP -4.68%
F VTRS -4.22%
D ELAN -4.12%
D LLY -4.04%
C JAZZ -3.55%
D PRGO -2.05%
F RPRX -1.33%
D PCRX -1.09%
F FOLD -1.01%
F RETA -0.92%
D CORT -0.91%
F CCXI -0.88%
D ITCI -0.86%
B PBH -0.84%
D ARVN -0.77%
C RVNC -0.7%
B IRWD -0.65%
F AXSM -0.52%
D ENDP -0.52%
B MDGL -0.46%
C CARA -0.45%
D OMER -0.43%
F ZGNX -0.41%
B TBPH -0.4%
D VNDA -0.34%
D AERI -0.31%
D COLL -0.3%
C INVA -0.28%
D AMRX -0.25%
F AMPH -0.24%
D NGM -0.22%
F AVIR -0.21%
B PAHC -0.19%
D RLMD -0.19%
F PHAT -0.18%
F PRVB -0.16%
F SPPI -0.16%
C CPRX -0.16%
F TXMD -0.16%
Compare ETFs